The US Food and Drug Administration fully approved the Pfizer COVID vaccine - meaning that it is now permanently approved for use in those aged 16 and over.
Study suggests that long COVID patients are more likely to face blood-clots - even if they appeared okay, their clotting biomarkers were significantly high.
Global "vaccine nationalism" is the dominant approach to the virus so far - but according to researchers at Princeton and McGill University, this mentality increases the chances of a new variant.
NHS GP and lead GP at Numan, Dr Luke Pratsides tells us everything he knows about the symptoms of long COVID and what’s being done to tackle this novel disease.
The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.
Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.
The BMJ Global Health study looks at how the "eradication of COVID-19" could work - if high vaccination happens in every country, and all vaccines remain up-to-date.
Dr Tedros Ghebreyesus, WHO leader, asked richer countries in the Global North to wait before giving third COVID jabs - as the Global South is yet to hit 10% double-vaccinated, due to low vaccine supply.
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.
